Height adjusted total kidney volume (HtTKV) is used in patients with autosomal dominant polycystic kidney disease to predict the onset of renal insufficiency. There is strong evidence to indicate that baseline htTKV predicts, with good sensitivity and specificity, the development of renal insufficiency within 8 years.